Post-Market Review of medicines available on the PBS Opiate Dependence Treatment Program
Page last updated: 24 March 2021
The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical Benefits Scheme (PBS) Opiate Dependence Treatment Program including consideration of patient access and affordability.
The Pharmaceutical Benefits Advisory Committee will consider the review.
Further information including Terms of Reference to follow.